# liothyronine sodium

NDC: 50090-7518
Generic name: liothyronine sodium
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191128

FDA application: ANDA091382

## Active ingredients

- LIOTHYRONINE SODIUM: 5 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-7518"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-7518
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d6b6f92-89e8-497a-ab23-d0afa2137d1f